[New approaches to target leukemia stem cells]

Katsuto Takenaka, Koichi Akashi

研究成果: ジャーナルへの寄稿記事

抄録

Human acute myeloid leukemia is organized as a hierarchy initiated and maintained by "leukemia stem cells(LSC)" which possesses self-renewal capacity. LSCs are therapeutic targets and must be eliminated to cure the patients. Recent advances in LSC research provided insights into the cell surface antigens preferentially expressed on AML-LSCs compared with normal hematopoietic stem cells and the signaling pathways defining the LSC characteristics. These molecules are potential targets to eradicate LSCs. Especially, monoclonal antibodies targeting surface antigens expressed on LSCs, including CD123, CD44, TIM-3 and CD47 have been shown its efficacy against AML-LSCs in xenotransplant models.

元の言語英語
ページ(範囲)1018-1025
ページ数8
ジャーナルNihon rinsho. Japanese journal of clinical medicine
72
発行部数6
出版物ステータス出版済み - 6 1 2014

Fingerprint

Leukemia
Stem Cells
Surface Antigens
Stem Cell Research
Hematopoietic Stem Cells
Acute Myeloid Leukemia
Monoclonal Antibodies
Therapeutics

All Science Journal Classification (ASJC) codes

  • Medicine(all)

これを引用

[New approaches to target leukemia stem cells]. / Takenaka, Katsuto; Akashi, Koichi.

:: Nihon rinsho. Japanese journal of clinical medicine, 巻 72, 番号 6, 01.06.2014, p. 1018-1025.

研究成果: ジャーナルへの寄稿記事

@article{0d865b512e8f4f28942fffd9ef5d24ac,
title = "[New approaches to target leukemia stem cells]",
abstract = "Human acute myeloid leukemia is organized as a hierarchy initiated and maintained by {"}leukemia stem cells(LSC){"} which possesses self-renewal capacity. LSCs are therapeutic targets and must be eliminated to cure the patients. Recent advances in LSC research provided insights into the cell surface antigens preferentially expressed on AML-LSCs compared with normal hematopoietic stem cells and the signaling pathways defining the LSC characteristics. These molecules are potential targets to eradicate LSCs. Especially, monoclonal antibodies targeting surface antigens expressed on LSCs, including CD123, CD44, TIM-3 and CD47 have been shown its efficacy against AML-LSCs in xenotransplant models.",
author = "Katsuto Takenaka and Koichi Akashi",
year = "2014",
month = "6",
day = "1",
language = "English",
volume = "72",
pages = "1018--1025",
journal = "Astrophysical Journal",
issn = "0004-637X",
publisher = "IOP Publishing Ltd.",
number = "6",

}

TY - JOUR

T1 - [New approaches to target leukemia stem cells]

AU - Takenaka, Katsuto

AU - Akashi, Koichi

PY - 2014/6/1

Y1 - 2014/6/1

N2 - Human acute myeloid leukemia is organized as a hierarchy initiated and maintained by "leukemia stem cells(LSC)" which possesses self-renewal capacity. LSCs are therapeutic targets and must be eliminated to cure the patients. Recent advances in LSC research provided insights into the cell surface antigens preferentially expressed on AML-LSCs compared with normal hematopoietic stem cells and the signaling pathways defining the LSC characteristics. These molecules are potential targets to eradicate LSCs. Especially, monoclonal antibodies targeting surface antigens expressed on LSCs, including CD123, CD44, TIM-3 and CD47 have been shown its efficacy against AML-LSCs in xenotransplant models.

AB - Human acute myeloid leukemia is organized as a hierarchy initiated and maintained by "leukemia stem cells(LSC)" which possesses self-renewal capacity. LSCs are therapeutic targets and must be eliminated to cure the patients. Recent advances in LSC research provided insights into the cell surface antigens preferentially expressed on AML-LSCs compared with normal hematopoietic stem cells and the signaling pathways defining the LSC characteristics. These molecules are potential targets to eradicate LSCs. Especially, monoclonal antibodies targeting surface antigens expressed on LSCs, including CD123, CD44, TIM-3 and CD47 have been shown its efficacy against AML-LSCs in xenotransplant models.

UR - http://www.scopus.com/inward/record.url?scp=84923210321&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84923210321&partnerID=8YFLogxK

M3 - Article

C2 - 25016798

AN - SCOPUS:84923210321

VL - 72

SP - 1018

EP - 1025

JO - Astrophysical Journal

JF - Astrophysical Journal

SN - 0004-637X

IS - 6

ER -